Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis.

Worzfeld T, Swiercz JM, Looso M, Straub BK, Sivaraj KK, Offermanns S.

J Clin Invest. 2012 Apr;122(4):1296-305. doi: 10.1172/JCI60568. Epub 2012 Mar 1.

2.

Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.

Rivas MA, Tkach M, Beguelin W, Proietti CJ, Rosemblit C, Charreau EH, Elizalde PV, Schillaci R.

Breast Cancer Res Treat. 2010 Jul;122(1):111-24. doi: 10.1007/s10549-009-0546-3. Epub 2009 Sep 18.

PMID:
19760502
4.

C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.

Grothey A, Hashizume R, Ji H, Tubb BE, Patrick CW Jr, Yu D, Mooney EE, McCrea PD.

Oncogene. 2000 Oct 5;19(42):4864-75.

5.

Grb2 mediates semaphorin-4D-dependent RhoA inactivation.

Sun T, Krishnan R, Swiercz JM.

J Cell Sci. 2012 Aug 1;125(Pt 15):3557-67. Epub 2012 Apr 14.

6.

Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1.

Rody A, Holtrich U, Gaetje R, Gehrmann M, Engels K, von Minckwitz G, Loibl S, Diallo-Danebrock R, Ruckhäberle E, Metzler D, Ahr A, Solbach C, Karn T, Kaufmann M.

Clin Cancer Res. 2007 Feb 15;13(4):1115-22.

7.

Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2.

Swiercz JM, Kuner R, Offermanns S.

J Cell Biol. 2004 Jun 21;165(6):869-80.

8.

Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.

Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ.

Cancer Res. 2004 May 1;64(9):3171-8.

9.

Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion.

Ye S, Hao X, Zhou T, Wu M, Wei J, Wang Y, Zhou L, Jiang X, Ji L, Chen Y, You L, Zhang Y, Xu G, Zhou J, Ma D, Wang S.

BMC Cancer. 2010 Nov 8;10:611. doi: 10.1186/1471-2407-10-611.

10.

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J.

J Clin Invest. 2008 Jan;118(1):64-78.

11.

Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.

Casazza A, Finisguerra V, Capparuccia L, Camperi A, Swiercz JM, Rizzolio S, Rolny C, Christensen C, Bertotti A, Sarotto I, Risio M, Trusolino L, Weitz J, Schneider M, Mazzone M, Comoglio PM, Tamagnone L.

J Clin Invest. 2010 Aug;120(8):2684-98. doi: 10.1172/JCI42118. Epub 2010 Jul 26. Erratum in: J Clin Invest. 2011 Jul 1;121(7):2945. Mazzone, Massimilano [corrected to Mazzone, Massimiliano].

12.
13.

Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis.

Laurin M, Huber J, Pelletier A, Houalla T, Park M, Fukui Y, Haibe-Kains B, Muller WJ, Côté JF.

Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7434-9. doi: 10.1073/pnas.1213050110. Epub 2013 Apr 16.

15.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

16.

Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin].

Staebler A, Sommers C, Mueller SC, Byers S, Thompson EW, Lupu R.

Breast Cancer Res Treat. 1994;31(2-3):175-82.

PMID:
7881097
17.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
18.

Tyrosine kinase receptor--nuclear protooncogene interactions in breast cancer.

Dickson RB, Salomon DS, Lippman ME.

Cancer Treat Res. 1992;61:249-73. Review.

PMID:
1360236
19.

Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.

Labriola L, Salatino M, Proietti CJ, Pecci A, Coso OA, Kornblihtt AR, Charreau EH, Elizalde PV.

Mol Cell Biol. 2003 Feb;23(3):1095-111.

20.

p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.

Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.

Cancer Res. 2006 May 1;66(9):4672-80.

Supplemental Content

Support Center